Back to STATE STREET CORP STATE STREET CORP

HALOHALO
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in HALOZYME THERAPEUTICS INC

STATE STREET CORP holds 5.2M shares of HALO (HALOZYME THERAPEUTICS INC), worth $405.4M as of 2026-Q2. The position was increased (+4.9% shares). HALO represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$405.4M

Current Shares

5.2M

Total Value Change

+$166M

Total Shares Change

-1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.2M
+4.9%
$405.4M0.0%$78.27
33
2026-Q1
Decreased
4.9M
-3.6%
$319.1M0.0%$69.40
0
2025-Q4
Increased
5.1M
+2.0%
$344.7M0.0%$67.70
32
2025-Q3
Decreased
5M
-15.4%
$368.1M0.0%$73.29
0
2025-Q2
Decreased
5.9M
-1.9%
$308.7M0.0%$52.21
0
2025-Q1
Decreased
6.1M
-15.8%
$386.2M0.0%$63.84
0
2024-Q4
Increased
7.2M
+8.3%
$343.5M0.0%$47.99
34
2024-Q3
Increased
6.6M
+14.1%
$379.7M0.0%$56.97
35
2024-Q2
Decreased
5.8M
-10.4%
$304.4M0.0%$52.36
0
2024-Q1
Increased
6.5M
+0.2%
$263.9M0.0%$40.68
31
2023-Q4
New
6.5M
-
$239.3M0.0%$36.96
43

Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used